HK40112955A - Chimeric compound for targeted degradation of androgen receptor protein, preparation method therefor, and medical use thereof - Google Patents

Chimeric compound for targeted degradation of androgen receptor protein, preparation method therefor, and medical use thereof Download PDF

Info

Publication number
HK40112955A
HK40112955A HK62024101088.8A HK62024101088A HK40112955A HK 40112955 A HK40112955 A HK 40112955A HK 62024101088 A HK62024101088 A HK 62024101088A HK 40112955 A HK40112955 A HK 40112955A
Authority
HK
Hong Kong
Prior art keywords
preparation
receptor protein
method therefor
androgen receptor
medical use
Prior art date
Application number
HK62024101088.8A
Other languages
Chinese (zh)
Inventor
杨方龙
贾敏强
陈刚
池江涛
贺峰
Original Assignee
江苏恒瑞医药股份有限公司
上海恒瑞医药有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 江苏恒瑞医药股份有限公司, 上海恒瑞医药有限公司 filed Critical 江苏恒瑞医药股份有限公司
Publication of HK40112955A publication Critical patent/HK40112955A/en

Links

HK62024101088.8A 2021-11-25 2022-11-25 Chimeric compound for targeted degradation of androgen receptor protein, preparation method therefor, and medical use thereof HK40112955A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN202111413454.8 2021-11-25
CN202111624368.1 2021-12-28
CN202210097592.8 2022-01-27
CN202210203856.3 2022-03-03
CN202211083887.6 2022-09-06

Publications (1)

Publication Number Publication Date
HK40112955A true HK40112955A (en) 2025-01-28

Family

ID=

Similar Documents

Publication Publication Date Title
EP4438603A4 (en) Chimeric compound for targeted degradation of androgen receptor protein, preparation method therefor, and medical use thereof
EP4209490A4 (en) Fused imidazole derivative, preparation method therefor, and medical use thereof
EP4242202A4 (en) Benzimidazole derivative and preparation method therefor and medical use thereof
EP3896033A4 (en) Device for open-type continuous growth of carbon nanomaterial, and preparation method
EP3991498A4 (en) Method and apparatus for configuring priority of uci
EP4021320A4 (en) Method and devices for implantation of biologic constructs
EP4026536A4 (en) Cationic nanodrug, preparation method therefor, and drug-loaded implantable medical device
EP4028034A4 (en) Chimeric orthogonal receptor proteins and methods of use
EP4345105A4 (en) Polypeptide derivative having effect of dual targeted activation of glp-1r and gipr, preparation method therefor, and use thereof
EP4238958A4 (en) 2-cyanoacrylate compound, preparation method therefor and use thereof
EP3950693A4 (en) Thienoheterocyclic derivative, preparation method therefor and medical use thereof
EP4317136A4 (en) Anhydrous polymorphs of androgen receptor antagonist, preparation method therefor, and use thereof
EP4192504A4 (en) Therapeutic cure-pro compounds for targeted degradation of bet domain proteins, and methods of making and using them
HK40112955A (en) Chimeric compound for targeted degradation of androgen receptor protein, preparation method therefor, and medical use thereof
EP3939629A4 (en) Medical tube and preparation method therefor
EP3763728A4 (en) Glycopeptide compounds having activity of resisting drug-resistant bacteria, and preparation method therefor and application thereof
EP3973778A4 (en) Freeze-resistant disinfectant composition and preparation method therefor
ZA202209741B (en) Dihydronaphthyridinone compound, and preparation method therefor and medical use thereof
EP3766874A4 (en) Preparation method for hexahydrofuro-furan-ol derivative and intermediate of derivative and preparation method therefor
EP4082556A4 (en) Compound preparation for neuranagenesis, and preparation method therefor and use thereof
EP4353729A4 (en) Polymorph of imidazolidinone compound, preparation method therefor and use thereof
EP3985009A4 (en) B crystal form of tetrahydrothienopyridine compound, preparation method therefor, composition and application
EP3913021A4 (en) Medical material and preparation method therefor
CA3259653A1 (en) Bifunctional compound and pharmaceutical composition comprising the bifunctional compound, and method for treating androgen receptor related diseases by using the same
EP4219476A4 (en) Salt of arylaminoquinazoline-containing compound, and preparation method therefor and use thereof